FEBRUARY 18, 2012

Browse Categories

AUA 2009 - Stone Disease: Research/New Technology - The First Drug Eluting Ureteral Stent: A Prospective, Randomized Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of a Ketorolac-Loaded Ureteral Stent - Session Highlights

Wed, 29 April 2009  |  Ralph V. Clayman, MD
E-mail Print

CHICAGO, IL, USA (UroToday.com) - In this level I evidence study, 276 patients were randomized to receive a ketorolac impregnated drug eluting stent (13% drug by weight) or a control nondrug eluting stent for up to 10 days.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |